News

[20.03.2018] Press release of the European Society of Cardiology (ESC) on AXAFA - AFNET 5 [read more]
[20.03.2018] Atrial fibrillation ablation with continuous Apixaban does not increase the risk of stroke or bleeding compared to vitamin K antagonists and may have... [read more]
[01.08.2017] AFNET is happy to announce to have joined Twitter! From now on we will keep you informed with any news on our trials. Follow us on Twitter!     [read more]
[30.08.2016] On August 27th 2016 the ESC isued a press release on new AF Guidelines. AFNET scientists and Prof. Kirchhof as head of the task force were involved.... [read more]
[22.06.2016] Atrial fibrillation (AF) is a common cause of stroke, and it is well established that oral anticoagulation provides efficient stroke prevention in AF... [read more]
[10.06.2016] AFNET scientists were significantly involved. The consensus paper was presented at CARDIOSTIM EHRA EUROPACE 2016 on June 10th, 11:00-12:30, in Nice.... [read more]
[30.05.2016] The pan-European clinical trial “Early treatment of atrial fibrillation for stroke prevention trial (EAST)” investigates whether early rhythm control... [read more]
[18.01.2016] Using catheter ablation to create complete linear lesions around pulmonary veins, proved more effective than the creation of incomplete lesions in... [read more]
[19.10.2015] At least 30 million people worldwide live with atrial fibrillation (AF). Despite improved treatment options AF patients still suffer strokes, heart... [read more]
[19.06.2015] Today the 2000th patient has been enrolled in the EAST – AFNET 4 trial. The pan-European clinical trial “Early treatment of atrial fibrillation for... [read more]

Pages